NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for FCAP yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Net income grows to at least $4.33 million in 2026-Q1 | First Capital grows net income steadily, reaching $4.33 million in 2026-Q1. | Intact | Net income falls below $4 million in any quarter after 2026-Q1 | Net income: $4.762M FY2026-Q2; GAAP. Published target: >=4.33 million USD. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 12, 20264,762,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
FCAP is a financial-sector investment with a strong recent-performance profile, rather than a clear turnaround story. Its long-term thesis is intact, but consistent earnings growth, dividend stability, and operating cash flow remain priorities to watch.
The evidence labels FCAP cheap, while its valuation is 1.21 times the peer level and expectations are close to aligned. The priced-in assessment is justified, with low fragility; valuation also fell by 10.3 points recently.
Recent financial performance is in the top half of its industry, and the latest listed event is an October 23 earnings release, with no result details provided. Near term, a guidance cut is a meaningful risk, while management’s stated priorities remain consistent net income growth, stable dividends, and strong operating cash flow.
The multi-year view depends on FCAP sustaining earnings growth, dividend stability, and cash generation. Near term, a guidance cut or Federal Reserve rate cuts could weigh on the setup; continued strong results and higher guidance from sector bellwethers could support sector momentum.
For the next 1 to 3 years, FCAP’s thesis remains intact on strong recent performance, but elevated risk and execution priorities warrant attention. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Operating cash flow stays positive and strong, hitting up to $7.94 million in 2025-Q3. |
| Intact |
| Operating cash flow falls below $3.7 million in any quarter |
Cash from operations: $4.251M FY2026-Q2; GAAP. Published target: >3.7 million USD. Target period is not explicitly aligned with this observation. Aug 12, 20264,251,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Dividends per share remain stable near $0.31 | Dividends remain stable near $0.31 per share, supporting income returns. | Intact | Dividend per share falls below $0.29 in any quarter after 2026-Q1 | Dividend per share: $0.31 per share FY2026-Q2; GAAP. Published target: >=0.29 USD per share. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Aug 12, 20260.31 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.